← Scoopfeeds — Intelligent news, curated.
Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC
business

Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC

Yahoo Finance · Jun 4, 2026, 9:05 AM · Also reported by 1 other source

Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Edesa reports exploratory data on AKI treatment candidate

More in business

MarketWatch
This hot new financial product has Wall Street spooked. What you should know before trying it out.
Investing.com
Marvell Technology options trading surges to 605,010 contracts
Investing.com
TerraVest stock plunges on insider tipping allegations
Investing.com
Mondelez options trading jumps to 3,842 contracts
Investing.com
AngloGold Ashanti options trading jumps to 4,786 contracts
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop